← Back to Search

Superficial Cervical Plexus Block for Post-Procedural Neck Pain

N/A
Recruiting
Led By Robert Stenberg, MD
Research Sponsored by Cleveland Clinic Akron General
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients who require IJVC as a part of their clinical care
Be older than 18 years old
Must not have
Patients who undergo CPR
Patients who are intubated
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes post central line placement
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at whether a certain pain-relieving medication can help reduce pain for people who have had a tube inserted through a vein in their neck.

Who is the study for?
This trial is for adults over 18 who visit the Akron General Emergency Department between March 1, 2021 and December 1, 2022, and need an internal jugular vein central line (IJVC). It's not for those who are intubated or have had CPR, allergies to local anesthetics like lidocaine or bupivacaine, skin infections near the neck veins, abnormal neck anatomy or prior surgeries in that area.
What is being tested?
The study is comparing two methods of pain control after placing a central line in the neck. One group will receive a superficial cervical plexus block (SCPB), while the other will get a standard local infiltrate. The goal is to see which method better reduces patient pain during this procedure.
What are the potential side effects?
Possible side effects may include discomfort at injection site, bruising, nerve damage risk with SCPB technique leading to weakness or numbness around the neck and shoulder area. Allergic reactions to anesthesia used could also occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need an internal jugular vein catheter for my treatment.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have undergone CPR.
Select...
I am currently on a breathing machine.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes post central line placement
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes post central line placement for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Visual Analog Scale Rating
Secondary study objectives
Complications

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SCPBExperimental Treatment1 Intervention
Group II: Local InfitrateActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Superficial Cervical Plexus Block
2014
N/A
~40

Find a Location

Who is running the clinical trial?

Cleveland Clinic Akron GeneralLead Sponsor
7 Previous Clinical Trials
442 Total Patients Enrolled
Akron General Medical CenterLead Sponsor
6 Previous Clinical Trials
238 Total Patients Enrolled
Robert Stenberg, MDPrincipal InvestigatorCleveland Clinic Akron General

Media Library

Local Infiltrate Clinical Trial Eligibility Overview. Trial Name: NCT05252832 — N/A
Pain Research Study Groups: SCPB, Local Infitrate
Pain Clinical Trial 2023: Local Infiltrate Highlights & Side Effects. Trial Name: NCT05252832 — N/A
Local Infiltrate 2023 Treatment Timeline for Medical Study. Trial Name: NCT05252832 — N/A
~10 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top